Safety studies on intravenous administration of oncolytic recombinant vesicular stomatitis virus in purpose-bred beagle dogs. - Wikidata - awgldk - TriplyDB

Safety studies on intravenous administration of oncolytic recombinant vesicular stomatitis virus in purpose-bred beagle dogs.

Safety studies on intravenous administration of oncolytic recombinant vesicular stomatitis virus in purpose-bred beagle dogs.

http://www.wikidata.org/entity/Q34013572

about

Safety Studies in Tumor and Non-Tumor-Bearing Mice in Support of Clinical Trials Using Oncolytic VSV-IFNβ-NIS.Oncolytic viruses: From bench to bedside with a focus on safety.Attenuated Semliki Forest virus for cancer treatment in dogs: safety assessment in two laboratory Beagles.Newcastle Disease Virus: Potential Therapeutic Application for Human and Canine Lymphoma.Safety and biodistribution of a double-deleted oncolytic vaccinia virus encoding CD40 ligand in laboratory Beagles Murine Tumor Models for Oncolytic Rhabdo-Virotherapy.Perfusion Pressure Is a Critical Determinant of the Intratumoral Extravasation of Oncolytic Viruses Progress in Adaptive Immunotherapy for Cancer in Companion Animals: Success on the Path to a Cure.On the potential of oncolytic virotherapy for the treatment of canine cancers.Robust Oncolytic Virotherapy Induces Tumor Lysis Syndrome and Associated Toxicities in the MPC-11 Plasmacytoma Model.Oncolytic Recombinant Vesicular Stomatitis Virus (VSV) Is Nonpathogenic and Nontransmissible in Pigs, a Natural Host of VSV.Oncolytic Virotherapy: A Contest between Apples and Oranges.VSV based virotherapy in ovarian cancer: the past, the present and …future?Anti-tumour activity of oncolytic Western Reserve vaccinia viruses in canine tumour cell lines, xenografts, and fresh tumour biopsies.Comparative oncology evaluation of intravenous recombinant oncolytic Vesicular Stomatitis Virus therapy in spontaneous canine cancer.Maraba virus-vectored cancer vaccines represent a safe and novel therapeutic option for cats.Recent advances in vesicular stomatitis virus-based oncolytic virotherapy: a 5-year update.Viral Vectors in Gene Therapy.White paper on microbial anti-cancer therapy and prevention Combination of IAP Antagonists and TNF-α-Armed Oncolytic Viruses Induce Tumor Vascular Shutdown and Tumor Regression Safety of an Oncolytic Myxoma Virus in Dogs with Soft Tissue Sarcoma

P2860

Q33434692-27F11E4F-A1BF-4B16-8704-4A17F1973127 Q34044071-922CD05F-85D7-41C2-B79D-DF90DCE002A1 Q35717021-B88DB230-8861-433D-9C57-F35A7E3B5110 Q36507259-005B5999-799E-4D4E-B1FA-6EACECB1E1BE Q36664201-26BC2736-37B0-4DAA-9257-EFE6AEBFA3DF Q36751597-28E30CBB-40DE-4AD9-960A-97CB6F481664 Q36756897-A0802973-80D0-4871-AE4C-01C3CDBFFE55 Q36781992-1904A6E1-12FB-4962-9821-67C509AA9067 Q37031925-4D46333E-8510-465C-AD10-EAD13A51E167 Q38734741-E2B21EBC-93CC-4BDC-A5A5-54BC17D1B9F5 Q38780400-211864F4-9E36-415D-80D8-26645FEF5155 Q39230055-7BA74183-FFA8-489B-8A75-9FBA3CB32251 Q41441101-C8B370C6-0E0D-467D-9FBE-5E98C8C264EC Q41706553-9D8E48BF-F8D8-4FF2-9907-3D23A8B1725D Q45324545-83140162-DA17-4510-AFBD-1248DF9D7A74 Q45324726-589FB749-8F68-402D-BF64-E7F295AC2C85 Q45324769-A741C041-15CA-463A-ABC9-82E489389901 Q55408780-0084A298-AEE4-449E-8A03-34CF8A9FA308 Q56898750-8216A18F-5B34-45CB-881C-A83290B5ABE4 Q57016734-DF8279D5-EB59-449B-A0CE-2DBD758D6843 Q59117175-8A369675-3394-4F1C-A486-79E7C7404DFF

P2860

Safety studies on intravenous administration of oncolytic recombinant vesicular stomatitis virus in purpose-bred beagle dogs.

http://www.wikidata.org/entity/Q34013572

description

2013 nî lūn-bûn

@nan

2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Safety studies on intravenous ...... s in purpose-bred beagle dogs.

@ast

Safety studies on intravenous ...... s in purpose-bred beagle dogs.

@en

Safety studies on intravenous ...... s in purpose-bred beagle dogs.

@nl

type

label

Safety studies on intravenous ...... s in purpose-bred beagle dogs.

@ast

Safety studies on intravenous ...... s in purpose-bred beagle dogs.

@en

Safety studies on intravenous ...... s in purpose-bred beagle dogs.

@nl

prefLabel

Safety studies on intravenous ...... s in purpose-bred beagle dogs.

@ast

Safety studies on intravenous ...... s in purpose-bred beagle dogs.

@en

Safety studies on intravenous ...... s in purpose-bred beagle dogs.

@nl

P1433

Q34013572-4FE9197B-3F43-4898-8D57-4807249E1835

P1476

Q34013572-63DEC944-414F-4A64-A3C1-32E07D6760D9

P2093

Q34013572-0DEC6DD1-2D8E-4951-8C57-8751CBFE3872

Q34013572-146ABBC7-2E77-415D-9A11-39925AEED224

Q34013572-4C686664-079C-4564-9929-7844A25464C6

Q34013572-666D1FFC-7287-4690-88E6-32E52B4BCC1D

Q34013572-879F386A-5EB6-4843-83C0-16F6E32CF6EF

Q34013572-B27AFDF3-8432-47D0-9534-D96F19E8E4FF

Q34013572-C1DCE057-B3E8-4DE1-8C1A-6F627A231043

P2860

Q34013572-0C59C4E0-DF99-4D57-A42A-5FE7511D50A1

Q34013572-14C1EE69-4030-46E5-84B4-662B23AF312D

Q34013572-327C3D8A-359D-46C9-86F1-B745EB7A680D

Q34013572-33C8286C-9816-4F64-B332-A746CB4147A4

Q34013572-4B568177-21CA-4FFB-A507-E3E853D3A1BB

Q34013572-610D80E6-499D-463F-91D0-349C2E431126

Q34013572-633B2151-2CEF-4062-BE16-4BE6F4D0238C

Q34013572-A5953002-690D-4311-91A1-082C5DB99D5B

Q34013572-B60E36C7-6D63-494C-8AE0-E0CF198DD131

Q34013572-BD304DB3-73B3-4B24-8576-F5E10C994C06

P304

Q34013572-1FF806D8-F9F9-4639-8C54-CCE1683B2D61

P31

Q34013572-1CB4BE0E-86FA-40E2-8356-695FC2244AEC

P356

Q34013572-1A9F54FC-BB6B-46D9-AD94-41EA64F5BE75

P433

Q34013572-E5691DEC-4CF1-4062-AC5D-4419013C0499

P478

Q34013572-3F561197-70D0-4FBD-91CB-705624060477

P50

Q34013572-09FEABE8-75DC-428E-99BC-D1F183E44454

Q34013572-C8A6AEC9-E227-44EB-98D8-727CEF27EE98

P577

Q34013572-692FC9B5-71BA-42E8-9957-415006215407

P698

Q34013572-DD0553E3-7EF9-43CF-8388-09A3E4576AB2

P921

Q34013572-4733F8A4-9897-4F9F-909D-DCB42EC2D239

P932

Q34013572-56B18F09-784E-4418-9104-87477BE7D379

P356

P1433

Human gene therapy. Clinical development

P1476

Safety studies on intravenous ...... s in purpose-bred beagle dogs.

@en

P2093

Amy K LeBlanc

http://www.w3.org/2001/XMLSchema#string

Gina D Galyon

http://www.w3.org/2001/XMLSchema#string

Mark J Federspiel

http://www.w3.org/2001/XMLSchema#string

Mike Steele

http://www.w3.org/2001/XMLSchema#string

Nathan Jenks

http://www.w3.org/2001/XMLSchema#string

Robert Donnell

http://www.w3.org/2001/XMLSchema#string

Shruthi Naik

http://www.w3.org/2001/XMLSchema#string

P2860

Attenuated vesicular stomatitis viruses as vaccine vectors

Safety studies on intrahepatic or intratumoral injection of oncolytic vesicular stomatitis virus expressing interferon-beta in rodents and nonhuman primates

Development of recombinant vesicular stomatitis viruses that exploit defects in host defense to augment specific oncolytic activity.

The role of Kupffer cell activation and viral gene expression in early liver toxicity after infusion of recombinant adenovirus vectors.

Vesicular stomatitis virus as an oncolytic vector.

Potent systemic therapy of multiple myeloma utilizing oncolytic vesicular stomatitis virus coding for interferon-β.

Curative one-shot systemic virotherapy in murine myeloma.

Comparative oncology today.

Viruses as anticancer drugs.

Engineering oncolytic viruses to exploit tumor specific defects in innate immune signaling pathways.

P304

174-181

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1089/HUMC.2013.165

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

24

http://www.w3.org/2001/XMLSchema#string

P50

Stephen J Russell

P577

2013-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24219832

http://www.w3.org/2001/XMLSchema#string

P921

oncolytic virus

P932

4124537

http://www.w3.org/2001/XMLSchema#string